Monaco Asset Management Sam Heron Therapeutics, Inc. Transaction History
Monaco Asset Management Sam
- $672 Million
- Q3 2024
A detailed history of Monaco Asset Management Sam transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Monaco Asset Management Sam holds 1,678,417 shares of HRTX stock, worth $2.05 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
1,678,417
Previous 1,513,164
10.92%
Holding current value
$2.05 Million
Previous $5.3 Million
36.93%
% of portfolio
0.5%
Previous 0.86%
Shares
6 transactions
Others Institutions Holding HRTX
# of Institutions
180Shares Held
121MCall Options Held
80.4KPut Options Held
94.9K-
Rubric Capital Management LP New York, NY26.7MShares$32.6 Million1.48% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.85MShares$10.8 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.72MShares$10.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$10.2 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$8.52 Million28.8% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $145M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...